{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:47:08Z","timestamp":1784400428518,"version":"3.55.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Obesity rates have risen in the United States since the 1980s. Several studies have shown links between obesity and the incidence of specific cancer types, but none have systematically examined obesity prevalence at the time of cancer diagnosis, or among clinical trial participants, all of which may affect clinical outcomes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine the prevalence of obesity and, separately, overweight and obesity over 30 years among patients with cancer enrolled in clinical treatment trials for obesity-related cancers; and to compare trends with corresponding trends in the US.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cohort study examined clinical treatment trials for obesity-related cancers conducted by the SWOG Cancer Research Network at community and academic sites. Participants included adult patients enrolled in phase 2 or phase 3 clinical treatment trials in obesity-related cancers between 1986 and 2016. Statistical analysis was performed from June 2020 to July 2022.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Year of enrollment to a clinical trial.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Prevalence of obesity (body mass index [BMI]\u2009\u2265\u200930) and overweight or obesity (BMI\u2009&amp;gt;\u200925) at the time of clinical trial enrollment. Multivariable logistic regression analysis, adjusted for demographic and clinical factors, was used to analyze patient height and weight collected at clinical trial enrollment.<\/jats:p><\/jats:sec>Results<\/jats:title>Among 23\u202f926 patients (median [IQR] age, 58 [51-66] years; 17\u202f594 [73.5%] female; 969 [4.0%] Hispanic, 2173 [9.1%] non-Hispanic Black, 19\u202f890 [83.1%] non-Hispanic White) enrolled between 1986 and 2016, unadjusted obesity rates increased from 23.5% (in 1986 to 1990 [n\u2009=\u2009657]) to 42.3% (in 2011 to 2016 [n\u2009=\u2009836]). There was an increasing linear trend in obesity (odds ratio [OR], 1.23 for each 5-year increase; 95% CI, 1.21-1.26; P<\/jats:italic>\u2009&amp;lt;\u2009.001), which persisted after covariate adjustment for demographic and clinical characteristics. Findings were consistent for the combined prevalence of overweight and obesity. The observed overall increasing trend in obesity prevalence from 1999-2000 to 2015-2016 was greater in trial patients (21.3% [SE\u2009=\u20090.7] to 49.1% [SE\u2009=\u20091.6]) than in US adults (30.5% [SE\u2009=\u20091.5] to 39.6% [SE\u2009=\u20091.6]) (P <\/jats:italic>for trend\u2009=\u2009.03), but was similar to US cancer survivors (18.9% [SE\u2009=\u20091.9] to 42.2% [SE\u2009=\u20092.1]; P <\/jats:italic>for trend\u2009=\u2009.31).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This cohort study found that patients with cancer and obesity are currently well-represented in cancer clinical trials, increasing confidence that trial findings are generalizable to patients with obesity in clinical practice. Availability of data on height and weight at diagnosis through cancer registries will enable a more rigorous analysis of obesity prevalence among patients with cancer.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.34445","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:22:02Z","timestamp":1665415322000},"page":"e2234445","source":"Crossref","is-referenced-by-count":11,"title":["Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016"],"prefix":"10.1001","volume":"5","author":[{"given":"Riha","family":"Vaidya","sequence":"first","affiliation":[{"name":"SWOG Statistics and Data Management Center, Seattle, Washington"},{"name":"Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathee","family":"Till","sequence":"additional","affiliation":[{"name":"SWOG Statistics and Data Management Center, Seattle, Washington"},{"name":"Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Greenlee","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn L.","family":"Hershman","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Unger","sequence":"additional","affiliation":[{"name":"SWOG Statistics and Data Management Center, Seattle, Washington"},{"name":"Fred Hutchinson Cancer Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"1","key":"zoi220982r1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","article-title":"Overweight and obesity in the United States: prevalence and trends, 1960\u20131994.","volume":"22","author":"Flegal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"219","key":"zoi220982r2","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011-2014.","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"21","key":"zoi220982r3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014.","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"issue":"23","key":"zoi220982r4","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1001\/jama.2018.7270","article-title":"Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013-2016.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"key":"zoi220982r5","doi-asserted-by":"publisher","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature.","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"issue":"9612","key":"zoi220982r7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"zoi220982r8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053916","article-title":"Obesity and risk of colorectal cancer: a systematic review of prospective studies.","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"zoi220982r9","doi-asserted-by":"publisher","DOI":"10.5402\/2013\/680536","volume":"2013","author":"Dobbins","year":"2013","journal-title":"ISRN Prev Med"},{"issue":"39","key":"zoi220982r10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.15585\/mmwr.mm6639e1","article-title":"Vital signs: trends in incidence of cancers associated with overweight and obesity - United States, 2005-2014.","volume":"66","author":"Steele","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"zoi220982r11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","article-title":"Adiposity and cancer risk: new mechanistic insights from epidemiology.","volume":"15","author":"Renehan","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"17","key":"zoi220982r12","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi220982r13","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1158\/1055-9965.EPI-12-0485","article-title":"The role of obesity in cancer survival and recurrence.","volume":"21","author":"Demark-Wahnefried","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"33","key":"zoi220982r14","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1200\/JCO.2015.63.1440","article-title":"Recommendations for obesity clinical trials in cancer survivors: American Society of Clinical Oncology statement.","volume":"33","author":"Ligibel","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"zoi220982r15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw206","article-title":"BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: The Pathways Study.","volume":"109","author":"Greenlee","year":"2016","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"zoi220982r16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11764-021-01012-y","volume":"16","author":"Timmins","year":"2022","journal-title":"J Cancer Surviv"},{"issue":"1","key":"zoi220982r17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1146\/med.2015.66.issue-1","article-title":"Impact of the obesity epidemic on cancer.","volume":"66","author":"Goodwin","year":"2015","journal-title":"Annu Rev Med"},{"issue":"4","key":"zoi220982r18","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1200\/JOP.2012.000623","article-title":"Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.","volume":"8","author":"Griggs","year":"2012","journal-title":"J Oncol Pract"},{"issue":"8","key":"zoi220982r19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrclinonc.2013.108","article-title":"Chemotherapy dosing in overweight and obese patients with cancer.","volume":"10","author":"Lyman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"zoi220982r20","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1634\/theoncologist.2017-0167","article-title":"Fixed dosing of monoclonal antibodies in oncology.","volume":"22","author":"Hendrikx","year":"2017","journal-title":"Oncologist"},{"issue":"26","key":"zoi220982r21","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1200\/JCO.2016.66.4391","article-title":"Trends in obesity prevalence in adults with a history of cancer: results from the US National Health Interview Survey, 1997 to 2014.","volume":"34","author":"Greenlee","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi220982r22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/jamaoncol.2018.5953","article-title":"Association of patient comorbid conditions with cancer clinical trial participation.","volume":"5","author":"Unger","year":"2019","journal-title":"JAMA Oncol"},{"issue":"8","key":"zoi220982r23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2013viewpoint of the IARC Working Group.","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi220982r27","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/annonc\/mdy138","volume":"29","author":"Pestine","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"zoi220982r28","doi-asserted-by":"publisher","first-page":"e213520","DOI":"10.1001\/jamanetworkopen.2021.3520","article-title":"Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis.","volume":"4","author":"Petrelli","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"zoi220982r29","doi-asserted-by":"publisher","first-page":"e199261","DOI":"10.1001\/jamanetworkopen.2019.9261","article-title":"Changes in age distribution of obesity-associated cancers.","volume":"2","author":"Koroukian","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi220982r30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1002\/cncr.31976","article-title":"Obesity and cancer treatment efficacy: existing challenges and opportunities.","volume":"125","author":"Ross","year":"2019","journal-title":"Cancer"},{"issue":"18","key":"zoi220982r31","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1200\/JCO.21.00471","article-title":"Appropriate systemic therapy dosing for obese adult patients with cancer: ASCO guideline update.","volume":"39","author":"Griggs","year":"2021","journal-title":"J Clin Oncol"},{"key":"zoi220982r32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejca.2019.12.031","article-title":"Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)\/ programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: a multicentre analysis of immune-related adverse events.","volume":"128","author":"Cortellini","year":"2020","journal-title":"Eur J Cancer"},{"issue":"16","key":"zoi220982r33","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity.","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"zoi220982r6","unstructured":"Marmot? M, Atinmo? T, Byers? T, . Food, nutrition, physical activity, and the prevention of cancer: a global perspective. World Cancer Research Fund \/ American Institute for Cancer Research. Published 2007. Accessed August 30, 2022. https:\/\/discovery.ucl.ac.uk\/id\/eprint\/4841\/1\/4841.pdf"},{"key":"zoi220982r24","unstructured":"National Cancer Institute. Targeted cancer therapies. Updated July 12, 2021. Accessed July 19, 2021. https:\/\/www.cancer.gov\/about-cancer\/treatment\/types\/targeted-therapies\/targeted-therapies-fact-sheet"},{"key":"zoi220982r25","doi-asserted-by":"crossref","unstructured":"Klein? R, Schoenborn? C. Age adjustment using the 2000 projected US population. Healthy People Statistical Notes, no. 20. Published January 2001. Accessed August 31, 2022. https:\/\/www.cdc.gov\/nchs\/data\/statnt\/statnt20.pdf","DOI":"10.1037\/e583772012-001"},{"key":"zoi220982r26","unstructured":"Fryar? CD, Carroll? MD, Ogden? C. Prevalence of overweight, obesity, and severe obesity among adults age 20 and over: United States, 1960-1962 through 2015-2016. CDC National Center for Health Statistics. Accessed August 31, 2022. https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-adult-17-18\/obesity-adult.htm"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2797074\/vaidya_2022_oi_220982_1664382878.86307.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T15:22:12Z","timestamp":1665415332000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2797074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.34445","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}